Barclays lowered the firm’s price target on Clorox (CLX) to $130 from $139 and keeps an Underweight rating on the shares as part of a consumer staples Q4 earnings preview. Put simply, “it feels like there aren’t many places to hide in Staples these days,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target raised to $171 from $167 at JPMorgan
- Trump Trade: President-elect prepares executive orders to boost fossil fuels
- Wells Fargo upgrades Clorox to Equal Weight, raises price target to $157
- Clorox upgraded to Equal Weight from Underweight at Wells Fargo
- Clorox price target raised to $164 from $161 at Deutsche Bank